Taipei Exchange - Delayed Quote TWD

SynCore Biotechnology Co.,Ltd (4192.TWO)

Compare
33.40
-0.05
(-0.15%)
At close: 12:25:27 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
22,930.00
20,196.00
15,857.00
6,939.00
13,336.00
Cost of Revenue
21,154.00
19,675.00
6,771.00
3,970.00
7,146.00
Gross Profit
1,776.00
521.00
9,086.00
2,969.00
6,190.00
Operating Expense
11,928.00
46,023.00
200,559.00
461,588.00
401,835.00
Operating Income
-10,152.00
-45,502.00
-191,473.00
-458,619.00
-395,645.00
Net Non Operating Interest Income Expense
1,941.00
1,585.00
-847.00
-1,010.00
-2,151.00
Pretax Income
364.00
-38,172.00
-188,666.00
-458,597.00
-398,918.00
Net Income Common Stockholders
364.00
-38,172.00
-188,666.00
-458,597.00
-398,918.00
Diluted NI Available to Com Stockholders
364.00
-38,172.00
-188,666.00
-458,597.00
-398,918.00
Basic EPS
0.24
-1.19
-6.14
-14.89
-14.11
Diluted EPS
0.24
-1.19
-6.14
-14.89
-14.11
Basic Average Shares
35,486.88
32,058.00
30,745.00
30,842.77
28,254.22
Diluted Average Shares
35,486.88
32,058.00
30,745.00
30,842.77
28,254.22
Total Expenses
33,082.00
65,698.00
207,330.00
465,558.00
408,981.00
Net Income from Continuing & Discontinued Operation
364.00
-38,172.00
-188,666.00
-458,597.00
-398,918.00
Normalized Income
364.00
-38,172.00
-188,666.00
-458,597.00
-398,918.00
Interest Income
2,187.00
2,369.00
1,424.00
1,025.00
1,235.00
Interest Expense
246.00
784.00
2,271.00
2,035.00
3,386.00
Net Interest Income
1,941.00
1,585.00
-847.00
-1,010.00
-2,151.00
EBIT
610.00
-37,388.00
-186,395.00
-456,562.00
-395,532.00
EBITDA
18,840.00
-17,726.00
-146,325.00
-404,130.00
-339,068.00
Reconciled Cost of Revenue
21,154.00
19,675.00
6,771.00
3,970.00
7,146.00
Reconciled Depreciation
18,230.00
19,662.00
40,070.00
52,432.00
56,464.00
Net Income from Continuing Operation Net Minority Interest
364.00
-38,172.00
-188,666.00
-458,597.00
-398,918.00
Normalized EBITDA
18,840.00
-17,726.00
-146,325.00
-404,130.00
-339,068.00
12/31/2020 - 8/29/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.75
+0.33%
 
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%
 
4728.TWO Sunmax Biotechnology Co., Ltd.
275.00
+0.18%
 
4168.TWO GlycoNex Incorporation
24.00
0.00%
 
6461.TWO Intech Biopharm Corporation
24.85
+0.20%
 
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
 
6662.TWO BioLASCO Taiwan Co., Ltd.
33.00
-0.30%
 
4178.TWO StemCyte International, Ltd.
35.15
+1.59%
 
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
 
3118.TWO Level Biotechnology Inc.
32.35
-0.15%